Will Kohl's supplier finance program balance exceed $150M by end of FY2026?

The key data point — FY2025 supplier finance balance — remains unknown until the 10-K filing in April 2026. This is the dominant source of uncertainty. The directional evidence from earnings is negative for this market: $674M cash, $1.4B OCF, and revolver exit all reduce the operational incentive for supplier finance as a cash management tool. The original thesis was that supplier finance growth was driven by cash flow pressure — that pressure has reversed dramatically. However, supplier finance programs tend to persist once established because they benefit all parties. The program may have grown from $97M toward $130M during FY2025 on momentum even as cash flow improved, or it may have stabilized. Without data, I assign 38% — down from 59% reflecting reduced incentive, but still substantial given the unknown trajectory.

I reason from the incentive structure. The prior 410% growth (from $19M to $97M) was driven by cash flow stress during FY2024 when revenue declined 7.2% and operating CF was struggling. FY2025 delivered the opposite: OCF surged to $1.4B, cash grew $540M, revolver exited. The fundamental driver of supplier finance expansion has reversed. Additionally, inventory is down ~7% with guidance for further reduction, meaning fewer purchase obligations and less need for payment term extension. The market requires the balance to exceed $150M — a 55% increase from $97M — during FY2026. For this to happen, either: (1) the program already grew significantly during FY2025 (possible but inconsistent with improved cash flow), or (2) there is a renewed cash flow deterioration in FY2026 driving expansion (unlikely given guidance). I assign 35%.

I take a more uncertain view. While the cash flow improvement argues against expansion, there are counterfactuals: (1) The $568M in additions during FY2024 suggests the program is already large in flow terms — even if growth slowed, the balance could have grown. (2) Supplier finance programs are often managed by treasury teams with targets independent of overall cash position — they optimize working capital metrics regardless of liquidity. (3) The balance is seasonal — year-end timing matters for when suppliers participate. (4) Two of the four aggressive accounting practices flagged by Fugazi Filter remain pending 10-K confirmation. I cannot rule out that the balance grew toward $120-130M during FY2025, from which $150M during FY2026 is a modest further step. The LOW confidence reflects genuine inability to estimate without the FY2025 data point.

The prediction context correctly identifies this as a high-uncertainty market pending the 10-K disclosure. The cash flow transformation ($1.4B OCF, $674M cash) fundamentally changes the narrative from 'desperate for cash, expanding supplier finance' to 'cash-rich, supplier finance may be unnecessary.' However, inertia in corporate finance programs is real. The program exists, vendors participate, and treasury teams have established processes. The balance likely grew during FY2025 — perhaps to $110-120M — but the rate of growth should have slowed as cash pressure eased. The $150M threshold requires the balance to be at that level at any quarter-end during FY2026, giving four measurement points. I assign 36%.

I take a more cautious view on the downshift. The supplier finance program grew 410% when cash was tight, but the relationship is not purely mechanical. Companies use supplier finance for strategic working capital optimization, not just distress management. Walmart, Amazon, and other large retailers maintain massive supplier finance programs despite abundant cash. Kohl's may continue growing the program simply because it is good treasury management — extending payment terms while suppliers get paid on time through intermediaries. The $150M threshold is only 55% above $97M. If the program grew at even half its FY2024 rate during FY2025, the balance could already be $140M+. I weight this scenario at 42%.

I focus on what has changed. The original assessment weighted four concerns equally: supplier finance surge, anomalous 3.9% ETR, insufficient impairment, revolver draw-up. Two of these have resolved favorably: tax rate normalized to 16% (on path to 22% guided), revolver fully exited. If the accounting aggressiveness thesis was correct — that management was systematically optimizing reported numbers during stress — the easing of stress should reduce the need for such optimization. Additionally, accounting scrutiny increases as companies improve (auditors and analysts look for reversals). I assign 34%, below the prior 59%, reflecting the directional shift but acknowledging the unknown FY2025 balance.

No supplier finance data disclosed in earnings call. Cash position dramatically improved. The incentive structure for expanding supplier finance has weakened. But program inertia and four quarterly measurement points maintain meaningful probability. The 10-K in April will be decisive. Assign 38% reflecting uncertainty.

The prior 59% was based on 410% growth trajectory during cash stress. Cash stress has reversed ($1.4B OCF, $674M cash). Growth trajectory should moderate significantly. The $150M threshold requires 55% growth from $97M. With reduced incentive and improving cash flow, this growth rate seems unlikely unless the program was already expanding during FY2025 on momentum. Assign 35%.

Programs once established tend to grow. The $568M in FY2024 additions shows significant flow. Even at a reduced addition rate, the balance could have grown during FY2025. If the FY2025 10-K reveals a balance of $120M+, the path to $150M during FY2026 is short. Without knowing the current trajectory, I weight slightly higher at 40%.